Mar-cof Cg Syrup
NDC Package 0682-0475-16
Package Information
Mar-cof Cg (codeine phosphate and guaifenesin) syrups is do not exceed 6 doses in 24 hours.Adults and children 12 years of age and over1 ½ tsp (7.5 mL) every 4-6 hoursChildren 6 to under 12 years of age¾ tsp (3.75 mL) every 4-6 hoursChildren under 6 years of ageConsult a doctor. This formulation utilizes a syrup delivery system. Marketed by Marnel Pharmaceuticals, Llc, this product is identified by NDC 0682-0475 and is authorized under FDA application M012.
Identification & Billing
- RxCUI: 995441 - codeine phosphate 7.5 MG / guaiFENesin 225 MG in 5 mL Oral Solution
- RxCUI: 995441 - codeine phosphate 1.5 MG/ML / guaifenesin 45 MG/ML Oral Solution
- RxCUI: 995441 - codeine phosphate 7.5 MG / guaifenesin 225 MG per 5 ML Oral Solution
- RxCUI: 995443 - MAR-COF CG 7.5 MG / 225 MG in 5 mL Oral Solution
- RxCUI: 995443 - codeine phosphate 1.5 MG/ML / guaifenesin 45 MG/ML Oral Solution [Mar-cof CG]
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 0682 - Marnel Pharmaceuticals, Llc
- 0682-0475 - Mar-cof Cg
- 0682-0475-16 - 473 mL in 1 BOTTLE
- 0682-0475 - Mar-cof Cg
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 0682-0475-16 identifies a specific commercial package of 473 ml in 1 bottle of Mar-cof Cg Expectorant, a human over the counter drug labeled by Marnel Pharmaceuticals, Llc. This syrup is formulated for oral use and contains codeine phosphate; guaifenesin as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Marnel Pharmaceuticals, Llc on December 01, 2008. The current certification is valid through December 31, 2026.
How is this Marnel Pharmaceuticals, Llc product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 00682047516. Quantities are measured in per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.. There are 473 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Labeler segment to maintain the 5-4-2 structure.